India is moving closer to commercialising a new tuberculosis vaccine — the HSP Subunit Vaccine in Adjuvant (DDA). Developed ...

The vaccine triggers strong immune responses against Mycobacterium tuberculosis and is licensed for commercial development to ...

Lucknow, Nov 24 (UNI) Uttar Pradesh Deputy Chief Minister Keshav Prasad Maurya stated on Monday that providing justice to ...

The HSP Subunit Vaccine candidate, jointly developed by the Institute of Life Sciences (ILS), Bhubaneswar, and the Indian Institute of Technology (IIT) Bhubaneswar, marks a significant advancement in ...

MUMBAI: A Kandivli couple's joy at having twins after IVF treatment was tinged with sadness as their boys were diagnosed with ...

India remains firmly on track in its fight against tuberculosis (TB) cases, said official sources in the Central TB Division ...

The Global TB Report 2025 released by the World Health Organization (WHO) highlights that India’s TB incidence has reduced ...

Lucknow, Nov 24: A two-day regional workshop for northern India under the TB-Free India campaign began in Lucknow on Monday, ...

Country's share in global TB burden narrowed from 27% in 2015 to 25% in 2024 but it still has the most cases in the world ...

Bhubaneswar: The Bhubaneswar-based Indian Institute of Technology (IIT), the Institute of Life Sciences (ILS) along with the ...

The WHO commends India for narrowing the TB detection gap and improving mortality rates, highlighting ongoing challenges in ...

WHO commends India for significant progress in reducing tuberculosis incidence and mortality, highlighting the need for ...